RNA sequencing analysis revealed the induction of CCL3 expression in human intracranial aneurysms.
Aged
Aneurysm, Ruptured
/ complications
Chemokine CCL3
/ genetics
Female
Gene Expression
/ genetics
Gene Ontology
Humans
Inflammation
/ complications
Intracranial Aneurysm
/ genetics
Macrophages
/ metabolism
Male
Middle Aged
Sequence Analysis, RNA
/ methods
Signal Transduction
Subarachnoid Hemorrhage
/ complications
Transcriptome
/ genetics
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 07 2019
17 07 2019
Historique:
received:
04
12
2018
accepted:
08
07
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
6
11
2020
Statut:
epublish
Résumé
Intracranial aneurysm (IA) is a socially important disease as a major cause of subarachnoid hemorrhage. Recent experimental studies mainly using animal models have revealed a crucial role of macrophage-mediated chronic inflammatory responses in its pathogenesis. However, as findings from comprehensive analysis of unruptured human IAs are limited, factors regulating progression and rupture of IAs in humans remain unclear. Using surgically dissected human unruptured IA lesions and control arterial walls, gene expression profiles were obtained by RNA sequence analysis. RNA sequencing analysis was done with read count about 60~100 million which yielded 6~10 billion bases per sample. 79 over-expressed and 329 under-expressed genes in IA lesions were identified. Through Gene Ontology analysis, 'chemokine activity', 'defense response' and 'extracellular region' were picked up as over-represented terms which included CCL3 and CCL4 in common. Among these genes, quantitative RT-PCR analysis using another set of samples reproduced the above result. Finally, increase of CCL3 protein compared with that in control arterial walls was clarified in IA lesions. Findings of the present study again highlight importance of macrophage recruitment via CCL3 in the pathogenesis of IA progression.
Identifiants
pubmed: 31316152
doi: 10.1038/s41598-019-46886-2
pii: 10.1038/s41598-019-46886-2
pmc: PMC6637171
doi:
Substances chimiques
CCL3 protein, human
0
Chemokine CCL3
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10387Références
Acta Neurochir Suppl. 2015;120:13-5
pubmed: 25366592
N Engl J Med. 2012 Jun 28;366(26):2474-82
pubmed: 22738097
Stroke. 2004 Oct;35(10):2287-93
pubmed: 15322297
No Shinkei Geka. 2018 Apr;46(4):275-294
pubmed: 29686161
Neurosurgery. 2006 Nov;59(5):1069-76; discussion 1076-7
pubmed: 17016232
J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):185-95
pubmed: 20487632
Stroke. 2011 Jan;42(1):173-8
pubmed: 21106959
Neuroscience. 2012 Jan 10;201:105-13
pubmed: 22079572
J Immunol. 2011 Feb 15;186(4):2482-94
pubmed: 21220697
Acta Neuropathol. 2012 Jun;123(6):773-86
pubmed: 22249619
World Neurosurg. 2014 Dec;82(6):1127-30
pubmed: 23548847
Circulation. 2014 Jan 21;129(3):373-82
pubmed: 24446407
Stroke. 2001 Feb;32(2):485-91
pubmed: 11157187
BMC Bioinformatics. 2014 May 16;15:144
pubmed: 24884663
Acta Neuropathol Commun. 2013 Oct 28;1:71
pubmed: 24252658
Neurosurgery. 1999 Nov;45(5):1137-46; discussion 1146-7
pubmed: 10549930
Lancet Neurol. 2014 Jan;13(1):59-66
pubmed: 24290159
Eur Neurol. 2009;62(6):330-7
pubmed: 19752560
Stroke. 2009 Mar;40(3):942-51
pubmed: 19164781
Sci Signal. 2017 Feb 07;10(465):
pubmed: 28174280
Ann Med. 2014 Dec;46(8):597-606
pubmed: 25117779
Cerebrovasc Dis. 2012;34(2):121-9
pubmed: 22965244
Stroke. 2011 Nov;42(11):3156-62
pubmed: 21980208
Neurosurg Rev. 2015 Jul;38(3):531-40; discussion 540
pubmed: 25860660
Expert Opin Ther Targets. 2010 Mar;14(3):265-73
pubmed: 20128708
Lancet. 2007 Jan 27;369(9558):306-18
pubmed: 17258671
AJNR Am J Neuroradiol. 2011 Jan;32(1):20-5
pubmed: 21071538
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):343-8
pubmed: 23697760
Oncotarget. 2017 Sep 28;8(62):104704-104705
pubmed: 29285206
Neuroscience. 2008 Jul 17;154(4):1398-407
pubmed: 18538937
Stroke. 2010 Feb;41(2):224-31
pubmed: 20044533
Stroke. 2009 Apr;40(4):1252-61
pubmed: 19228845